FDA reform of Class II and Class III device clearance/approval process - the 510(k) process H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices  Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
MED - Medical/Disease Research/Clinical Labs MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOMET, INC.
56 E. Bell Drive, P.O. Box 587, Warsaw, IN, 46581-0587, US
WILLIAM C KOLTER WILLIAM C KOLTER